Abstract:ABSTRACT While the entry of infectious bursal disease virus (IBDV) is initiated by the binding of the virus to the two major receptors integrin and HSP90, the signaling events after receptor binding and how they contribute to virus entry remain elusive. We show here that IBDV activates c-Src by inducing the phosphorylation of the Y416 residue in c-Src both in DF-1 chicken fibroblasts and in vivo in the bursa of Fabricius from specific-pathogen-free (SPF) chickens. Importantly, inactivated IBDV fails to stimulate c-Src Y416 phosphorylation, and a very virulent IBDV strain induces a much higher level of c-Src Y416 phosphorylation than does an attenuated strain. Inhibition of c-Src activation by an Src kinase inhibitor or expression of a c-Src dominant negative mutant results in a significant decrease in the internalization of IBDV but has little effect on virus adhesion. Furthermore, short hairpin RNA (shRNA) downregulation of integrin, either the α4 or β1 subunit, but not HSP90 remarkably attenuates IBDV-induced c-Src Y416 phosphorylation, resulting in a decrease in IBDV internalization but not virus adhesion. Moreover, interestingly, inhibition of either c-Src downstream of the phosphatidylinositol 3-kinase (PI3K)/Akt-RhoA signaling cascade or actin rearrangement leads to a significant decrease in IBDV internalization irrespective of the IBDV-induced high levels of c-Src phosphorylation. Cumulatively, our results suggest a novel feed-forward model whereby IBDV activates c-Src for benefiting its cell entry via an integrin-mediated pathway by the activation of downstream PI3K/Akt-RhoA signaling and cytoskeleton actin rearrangement. IMPORTANCE While IBDV-caused immunosuppression is highly related to viral invasion, the molecular basis of the cellular entry of IBDV remains elusive. In this study, we demonstrate that IBDV activates c-Src by inducing the phosphorylation of the Y416 residue in c-Src to promote virus internalization but not virus adhesion. The ability to induce the level of c-Src Y416 phosphorylation correlates with the pathogenicity of an IBDV strain. IBDV-induced c-Src Y416 activation is α4β1 integrin but not HSP90 dependent and involves the activation of the downstream PI3K/Akt-RhoA GTPase-actin rearrangement cascade. Thus, our findings provide new insights into the IBDV infection process and the potential for c-Src as a candidate target for the development of IBDV therapeutic drugs.

Engagement of Glucocorticoid-induced Leucine Zipper (GILZ) with Infectious Bursal Disease Virus (IBDV) VP4 Suppresses Type I Interferon Expression and Enhances IBDV Growth in Host Cells (168.13)

Critical Roles of Glucocorticoid-Induced Leucine Zipper in Infectious Bursal Disease Virus (Ibdv)-Induced Suppression of Type I Interferon Expression and Enhancement of IBDV Growth in Host Cells Via Interaction with VP4

Infectious Bursal Disease Virus Protein VP4 Suppresses Type I Interferon Expression Via Inhibiting K48-linked Ubiquitylation of Glucocorticoid-Induced Leucine Zipper (GILZ).

Infectious Bursal Disease Virus Activates C-Src to Promote Α4β1 Integrin-Dependent Viral Entry by Modulating the Downstream Akt-RhoA GTPase-Actin Rearrangement Cascade.

Generation of VP5 deficient mutant of infectious bursal disease virus strain HZ2

Synthesis of Reassortant Infectious Bursal Disease Virus in Chickens Injected Directly with Infectious Clones from Different Virus Strains

TMT-based quantitative proteomic analysis of IBDV-infected CEF cells reveals a favorable role of chicken IRF10 in IBDV replication via suppressing type-I interferon expression

Gga-Mir-454 Suppresses Infectious Bursal Disease Virus (IBDV) Replication Via Directly Targeting IBDV Genomic Segment B and Cellular Suppressors of Cytokine Signaling 6 (SOCS6).

gga-miR-155 Enhances Type I Interferon Expression and Suppresses Infectious Burse Disease Virus Replication via Targeting SOCS1 and TANK.

Eukaryotic Translational Initiation Factor 4AII Reduces the Replication of Infectious Bursal Disease Virus by Inhibiting VP1 Polymerase Activity

Cyclophilin A Interacts with Viral VP4 and Inhibits the Replication of Infectious Bursal Disease Virus

Infectious Bursal Disease Virus-Host Interactions: Multifunctional Viral Proteins That Perform Multiple and Differing Jobs

Identification of Novel T-cell Epitopes on Viral Protein VP4 of Infectious Bursal Disease Virus (IBDV) That Play Critical Roles in Eliciting Cellular Immune Response

Gga-Mir-27b-3p Enhances Type I Interferon Expression and Suppresses Infectious Bursal Disease Virus Replication Via Targeting Cellular Suppressors of Cytokine Signaling 3 and 6 (SOCS3 and 6).

[Expression of the Infectious Bursal Disease Virus Polyprotein in Vero Cells Using Attenuated Salmonella Typhimurium As Transgenic Carrier].

Gga-Mir-9* Inhibits IFN Production in Antiviral Innate Immunity by Targeting Interferon Regulatory Factor 2 to Promote IBDV Replication.

Ribosomal Protein L4 Interacts with Viral Protein VP3 and Regulates the Replication of Infectious Bursal Disease Virus

Surface IgM Λ Light Chain is Involved in the Binding and Infection of Infectious Bursal Disease Virus (IBDV) to DT40 Cells.

Infectious bursal disease virus replication is inhibited by avain T cell chemoattractant chemokine CCL19

Critical Role for Voltage-Dependent Anion Channel 2 in Infectious Bursal Disease Virus-Induced Apoptosis in Host Cells Via Interaction with VP5.

The association of ribosomal protein L18 (RPL18) with infectious bursal disease virus viral protein VP3 enhances viral replication